Stocks
Haemonetics Corporation (HAE) EBITDA US GAAP (year values) |
|||||||||
| 2023 | 2024 | 2024 | 2025 | 2026 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | 252.0 | 295.5 | 356.0 | 397.1 | 397.1 | |||
| Changes by years, y/y, % | +1% | -100% | +20% | +12% | +16.6% | ||||
Haemonetics Corporation. EBITDA US GAAP, bln rub
Haemonetics Corporation. EBITDA US GAAP, changes, %
Haemonetics Corporation. EBITDA US GAAP, sum by quarters, bln rub
Haemonetics Corporation (HAE) EBITDA US GAAP (quarter values) |
||||||||
| 2025Q4 | 2026Q1 | 2026Q2 | 2026Q3 | 2026Q4 | LTM ? | |||
| EBITDA, bln rub | ? | 99.5 | 93.7 | 86.8 | 95.5 | 121.2 | 397.1 | |
| Changes by years, y/y, % | +45% | +17% | -3% | +0% | +22% | |||
| Changes by quarters, q/q, % | +5% | -6% | -7% | +10% | +27% | |||
